Navigation Links
Cutaneous T-cell Lymphoma Shows Steady Increase

The cancer known as cutaneous T-cell lymphoma became substantially more common in the United States between 1973 and 2002 , according to a report in the July issue of Archives of Dermatology. The rates of the disease vary by race, sex and geographic area.

Cutaneous T-cell lymphoma occurs when certain cells of the lymph system (called T lymphocytes) become cancerous and affect the skin. The term covers several types of lymphoma, according to background information in the article. The nationwide rates of the disease were last documented in 1992.

Vincent D. Criscione, A.B., and Martin A. Weinstock, M.D., Ph.D., of the VA Medical Center, Rhode Island Hospital, and Brown University, Providence, R.I., used data from 13 cancer registries of the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute to describe incidence trends in cutaneous T-cell lymphoma from 1973 through 2002.

A total of 4,783 cases were identified in the 30-year period, a rate of 6.4 per million persons and a total of 0.14 percent of all cancers and 3.9 percent of non-Hodgkins lymphomas.

The overall incidence increased each decade, was higher among blacks than whites and among men than women, increased substantially with age, and varied geographically.

The San Francisco registry had the highest rates9.7 per million white individuals and 10.8 per million black individualswhile the Iowa registry had the lowest, with 3.7 per million white individuals and 5.8 per million among blacks.

The geographic differences in incidence are substantial even after controlling for race. Incidence is correlated with high physician density and several indexes of socioeconomic status such as median family income, percentage of the population with a bachelors degree or higher and median home value, the authors write.

These geographic differences in incidence may be related, to some degree, by diffe rences in access to medical care.

Changes and ambiguities in classifications and coding may be partially responsible for the increase in incidence over time, the authors note, as may improved detection and advances in medical technology.

An epidemiological investigation using population-based data is important to better understand this disorder, they conclude. However, these data may be useful in planning public health strategies, identifying risk factors and understanding the etiology of this cancer so that it may some day be prevented.


'"/>




Related medicine news :

1. T-cells Developed from Human Embryonic Stem Cells
2. Regulatory T-cells – Protector or Cause of Diseases
3. Lymphomas Link to Hepatitis C
4. No Lymphoma Risk From Rheumatoid Arthritis Drugs
5. New Guidelines For Assessing Lymphoma Treatment
6. A Novel Treatment for KSHV-infected Lymphomas
7. Long-term Oral Steroid Therapy Decreases Lymphoma Risk in Rheumatoid Arthritis
8. Study Finds Lymphoma Drug Effective Over Long Term
9. Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo
10. Risk of Lymphoma Increases With Hepatitis C Virus Infection
11. Experimental treatment for Ebola Virus Shows promising results in mice
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... 2016 , ... United Benefit Advisors (UBA), the nation’s leading ... its growing list of Partner Firms. S.S. Nesbitt is headquartered in Birmingham, ... and in between. , Harnessing the experience and insights of the agency’s team ...
(Date:2/10/2016)... MI (PRWEB) , ... February 10, 2016 , ... ... Apifiny® across their network of laboratory service centers across the country. Launched ... to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... For additional ... new book , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" ... can improve memory. The book’s publication date is March 16, 2016. A ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... Everseat digital self-scheduling readily available to physicians. The integration will enable ... find and select appointments via Everseat’s free mobile app. , The partnership gives ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Workrite Ergonomics this ... versatile series of monitor mounts ever. , “Our goal was to develop a ... to install system that we have ever created.” said Darren Hulsey, Product Manager for ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)...  Resolve Therapeutics, LLC, a clinical stage biopharmaceutical ... treatment of lupus and Sjogrens syndrome, today announced ... study in patients with systemic lupus erythematosus (SLE) ... --> --> Data from a ... of RSLV-132 in 32 subjects with SLE demonstrate ...
(Date:2/10/2016)...  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ("Rich Pharmaceuticals" ... of its issued and outstanding shares of common stock ... 11, 2016. The Company,s common stock will trade on ... temporary ticker symbol "RCHAD". After 20 trading days, the ... (RCHA).  --> --> ...
(Date:2/10/2016)... , Feb. 10, 2016  The ... Nursing received an in-kind gift from ... a VeinViewer® Vision vein finder for the ... help students as they learn how to ... technology with traditional technique. ...
Breaking Medicine Technology: